Impact of Genetic Reduction of NMNAT2 on Chemotherapy-Induced Losses in Cell Viability In Vitro and Peripheral Neuropathy In Vivo.
Nicotinamide mononucleotide adenylyl transferases (NMNATs) are essential neuronal maintenance factors postulated to preserve neuronal function and protect against axonal degeneration in various neurodegenerative disease states. We used in vitro and in vivo approaches to assess the impact of NMNAT2 r...
Main Authors: | Richard A Slivicki, Yousuf O Ali, Hui-Chen Lu, Andrea G Hohmann |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4726514?pdf=render |
Similar Items
-
Nmnat mitigates sensory dysfunction in a Drosophila model of paclitaxel-induced peripheral neuropathy
by: Jennifer M. Brazill, et al.
Published: (2018-06-01) -
Review of the Role of the Brain in Chemotherapy-Induced Peripheral Neuropathy
by: Maryam Omran, et al.
Published: (2021-06-01) -
Nmnat3 Is Dispensable in Mitochondrial NAD Level Maintenance In Vivo.
by: Masashi Yamamoto, et al.
Published: (2016-01-01) -
Chemotherapy-Induced Peripheral Neuropathy and Physiotherapy
by: Gro S. Haugen, et al.
Published: (2013-04-01) -
Mechanisms of Chemotherapy-Induced Peripheral Neuropathy
by: Renata Zajączkowska, et al.
Published: (2019-03-01)